1 |
Fernández J, Silván B, Entrialgo-Cadierno R, Villar CJ, Capasso R, Uranga JA, Lombó F, Abalo R. Antiproliferative and palliative activity of flavonoids in colorectal cancer. Biomed Pharmacother 2021;143:112241. [PMID: 34649363 DOI: 10.1016/j.biopha.2021.112241] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
2 |
Devan AR, Kumar AR, Nair B, Anto NP, Muraleedharan A, Mathew B, Kim H, Nath LR. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma. Pharmaceuticals (Basel) 2021;14:656. [PMID: 34358082 DOI: 10.3390/ph14070656] [Reference Citation Analysis]
|
3 |
Zughaibi TA, Suhail M, Tarique M, Tabrez S. Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach. Int J Mol Sci 2021;22:12455. [PMID: 34830339 DOI: 10.3390/ijms222212455] [Reference Citation Analysis]
|
4 |
Leischner C, Burkard M, Michel A, Berchtold S, Niessner H, Marongiu L, Busch C, Frank J, Lauer UM, Venturelli S. Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status. Molecules 2021;26:5586. [PMID: 34577057 DOI: 10.3390/molecules26185586] [Reference Citation Analysis]
|